-

Company Profile for Anova Enterprises, Inc.

--(BUSINESS WIRE)--Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.

Company:

Anova Enterprises, Inc.

 

 

Headquarters Address:

One Arlington Executive Center

 

3400 West Stonegate Boulevard, Suite 101

 

Arlington Heights, IL 60005

 

 

Main Telephone:

224-218-2408

 

 

Website:

www.anovaevidence.com

 

 

Type of Organization:

Private

 

 

Industry:

Health

 

 

Key Executives:

President: Martin Walsh

 

CEO: Chris Beardmore

 

 

Investor Relations

 

Contact:

Martin Walsh

Phone:

(224) 218-2408

Email:

martin@anovaevidence.com

 

 

Public Relations

 

Contact:

Louise Rayner

Phone:

(224) 218-2408

Email:

louise@anovaevidence.com

 

Anova Enterprises, Inc.

Details
Headquarters: Chicago, ILLINOIS
CEO: Christopher Beardmore
Employees: 21-50
Organization: PRI

Release Versions

Social Media Profiles
More News From Anova Enterprises, Inc.

Anova Launches Free AI-enabled Clinical Trial Patient Matching Solution as Part of a Global Just-in-time Research Network

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to improving the conduct of clinical trials, has today announced the launch of its new AI-enabled patient matching solution as part of a global just-in-time research network and clinical trial infrastructure. The solution matches patients to open and accruing clinical trials and promising investigational products for compassionate use. The platform, available at no cost to participating resear...

Anova Today Announced the Enrollment of 550+ Patients at 50+ Sites in Six Months for a Single Study

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to improving the conduct of clinical trials, today announced the completion of enrollment of 550+ patients at 50+ sites for a single study in just six months, using it’s proprietary AnovaOS™ Platform. The program provided cancer doctors and patients with a promising treatment that was otherwise unavailable. The sponsor was provided with safety and efficacy data to support its drug development...

Anova Launches Global Clinical Registry to Accelerate Research and Access to Promising New Treatments

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to improving the conduct of clinical trials, has announced the launch of a global clinical registry to accelerate the development of promising new treatments. The 21 CFR Part 11 compliant AnovaOS® global clinical registry provides a rich source of real-world evidence about research sites and patients, administrative efficiency in the conduct of research, a tool for post-market surveillance, an...
Back to Newsroom